Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Mesotherapy with bicalutamide has limited effectiveness for female hair loss.

Scientists made two new chemicals that might help treat diseases caused by male hormones.

A new compound effectively inhibits human 5α-reductase 1.

Spironolactone improved cognitive performance and early sleep quality but not manic symptoms, appetite, or body weight in bipolar disorder when added to sodium valproate.

Hair transplant surgery is a good cosmetic solution for people with little or no pubic hair, especially to boost their self-esteem.

Certain drugs that block specific enzymes can help treat prostate diseases.

Pubic hair transplant surgery is an effective and permanent treatment for pubic hair loss.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Compounds from Jatropha cordata bark have significant anti-inflammatory effects and could help with hair loss.

Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.

Acne is a common skin condition that can be influenced by diet, lifestyle, and hormones, and requires a treatment approach that includes psychological considerations.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

DHT reduces a cell's ability to promote hair growth, while 3D culture without DHT improves it.

Spironolactone may help reduce excessive hair growth in women with high male hormone levels.

Dexamethasone increases androgen receptor activity in scalp cells, which might explain stress-related hair loss.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Trazodone might help reverse post finasteride syndrome.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Long-term use of androgens can help manage Hereditary Angioedema (HAE) but may cause serious side effects, so alternative treatments with fewer side effects are being considered.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Dutasteride and finasteride affect different cell types differently.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Androgens increase norepinephrine release, promoting smooth muscle growth in male sex organs, which may contribute to benign prostatic hypertrophy.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.